HEMOSHEAR THERAPEUTICS, INC. — Form D

HEMOSHEAR THERAPEUTICS, INC. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-18. The offering totals $48.1M, of which $43.1M was reported sold. Industry: Other Health Care.

Offering

Filed: 2021-02-18
Form: D
Accession: 0001231919-21-000019
Industry: Other Health Care
Exemptions: 06b
Total offering: $48.1M
Amount sold: $43.1M
Remaining: $5.0M
Investors: 17
Date of first sale: 2021-02-05
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-389840

Issuer

Name: HEMOSHEAR THERAPEUTICS, INC.
CIK: 0001846099
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 501 LOCUST AVENUE, SUITE 301, CHARLOTTESVILLE, VA, 22902
Phone: 434 872-0196

Officers, directors & promoters (20)

Name	Role	Location
John L Brooks	Director	CHARLOTTESVILLE, VA
DAVID A FRIEDMAN	Director	EVANSTON, IL
James C Powers	Director	CHARLOTTESVILLE, VA
John A Tilton	Director	CHARLOTTESVILLE, VA
Aric R Holsinger	Executive Officer	CHARLOTTESVILLE, VA
James C Powers	Executive Officer	CHARLOTTESVILLE, VA
W. M Thompson, Jr.	Executive Officer	CHARLOTTESVILLE, VA
Brian Thomas Wamhoff	Executive Officer	CHARLOTTESVILLE, VA
Michael A Innes	Executive Officer	Charlottesville, VA
David L Friedman	Director	Charlottesville, VA
Patrick A Horn	Executive Officer	Charlottesville, VA
Brian A Johns	Executive Officer	Charlottesville, VA
John M Tilton	Director	Charlottesville, VA
H. Thomas Watkins III	Director	Charlottesville, VA
John L Brooks III	Director	Charlottesville, VA
Kathleen M Metters	Director	Charlottesville, VA
Aric Holsinger	Executive Officer	Charlottesville, VA
Brian M Warmhoff	Director	Charlottesville, VA
Brian M Warmhoff	Executive Officer	Charlottesville, VA
Robert J Gould	Director	Charlottesville, VA

Other filings by this issuer (1)

Filed	Form	Offering	Sold
2023-11-14	D	$8.0M	$3.5M

HEMOSHEAR THERAPEUTICS, INC. — Form D

Offering

Issuer

Officers, directors & promoters (20)

Other filings by this issuer (1)

More